Capricor Therapeutics (CAPR) EBIT (2010 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly EBIT of -$36.8 million in Q1 2026, down 26.12% quarter-over-quarter from -$29.2 million in Q4 2025, and down 47.19% on a YoY basis from -$69.6 million in Q1 2025.
Capricor Therapeutics (CAPR) EBIT (2010 - 2026) Analysis & Trends
Capricor Therapeutics' EBIT history runs 17 years deep, the most recent figure standing at -$36.8 million for Q1 2026.
- In Q1 2026, EBIT fell 47.19% year-over-year to -$36.8 million; the TTM figure through Mar 2026 stood at -$119.9 million (down 416.62% YoY), while the FY2025 annual figure was -$108.1 million, down 1172.59% from the prior year.
- EBIT was -$36.8 million for Q1 2026 at Capricor Therapeutics, down from -$29.2 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $26.4 million in Q4 2024 to a low of -$36.8 million in Q1 2026.
- Historically, EBIT has averaged -$12.2 million across 5 years, with a median of -$8.2 million in 2023.
- The sharpest annual moves came in 2024 and 2025: EBIT jumped 2158.02% in 2024, then plunged 210.57% in 2025.
- A 5-year view of EBIT shows it stood at -$8.1 million in 2022, then jumped by 84.12% to -$1.3 million in 2023, then surged by 2158.02% to $26.4 million in 2024, then slumped by 210.57% to -$29.2 million in 2025, then declined by 26.12% to -$36.8 million in 2026.
- The last three EBIT figures came in at -$36.8 million (Q1 2026), -$29.2 million (Q4 2025), and -$26.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | -36.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.77 Mn |
| Dec 31, 2025 | -29.16 Mn |
| Sep 30, 2025 | -26.28 Mn |
| Jun 30, 2025 | -27.72 Mn |
| Mar 31, 2025 | -24.98 Mn |
| Dec 31, 2024 | 26.37 Mn |
| Sep 30, 2024 | -13.01 Mn |
| Jun 30, 2024 | -11.59 Mn |
| Mar 31, 2024 | -10.27 Mn |
| Dec 31, 2023 | -1.28 Mn |
| Sep 30, 2023 | -6.86 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Mar 31, 2023 | -8.18 Mn |
| Dec 31, 2022 | -8.07 Mn |
| Sep 30, 2022 | -6.48 Mn |
| Jun 30, 2022 | -7.32 Mn |
| Mar 31, 2022 | -7.83 Mn |
| Dec 31, 2021 | -6.38 Mn |
| Sep 30, 2021 | -4.31 Mn |
| Jun 30, 2021 | -5.08 Mn |